adenosine diphosphate has been researched along with pyrimidinones in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernard, H; Boisseau, M; Casadebaig, F; Dupin, JP; Gravier, D; Hou, G | 1 |
| Bardi, A; Ferroni, R; Franze, GP; Guarneri, M; Orlandini, P; Simoni, D | 1 |
| Balabolkin, II; Gerasimova, IuV; Iurkov, IuA | 1 |
| Brown, PR; Parks, RE | 1 |
| Aprile, B; Di Braccio, M; Leoncini, G; Roma, G | 1 |
| Livne, AA; Packham, MA; Rand, ML; Ruben, DH | 1 |
| Braccio, MD; Carotti, A; Carrieri, A; Grazia Signorello, M; Grossi, G; Leoncini, G; Roma, G | 1 |
| Bonacorso, HG; Cechin, SR; Flores, DC; Madruga, CC; Martins, MA; Morsch, VM; Pacholski, IL; Schetinger, MR; Zanatta, N | 1 |
| Bhavaraju, K; Garcia, A; Kim, S; Kunapuli, SP; Schoenwaelder, SM | 1 |
| Bhatia, S; Medhi, B; Parmar, VS; Prasad, AK; Priya, N; Raj, HG; Singh, P | 1 |
| Geisler, T; Krajewski, S; Kurz, J; Peter, K; Straub, A; Wendel, HP | 1 |
11 other study(ies) available for adenosine diphosphate and pyrimidinones
| Article | Year |
|---|---|
Thieno[2,3-d]pyrimidin-4(3H)-one derivatives and 1,2-dihydrogenated homologues: synthesis, enhanced in vitro antiaggregant activity for reduced compounds.
Topics: Adenosine Diphosphate; Humans; Hydrogen; Oxidation-Reduction; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrimidinones | 1992 |
Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones.
Topics: Adenosine Diphosphate; Collagen; Guanidines; Humans; Imidazoles; In Vitro Techniques; Magnetic Resonance Spectroscopy; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Pyrazoles; Pyrimidines; Pyrimidinones; Structure-Activity Relationship; Triazines | 1990 |
[Comparative characteristics of certain indicators of metabolism in infectious-allergic and atopical forms of bronchial asthma in children].
Topics: 17-Hydroxycorticosteroids; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Asthma; Child; Child, Preschool; Glycosaminoglycans; Histidine; Humans; Purines; Pyrimidinones; Tryptamines | 1974 |
Incorporation of nucleosides into the nucleotide pools of human erythrocytes. Adenosine and its analogs.
Topics: Adenine Nucleotides; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aminohydrolases; Antibiotics, Antineoplastic; Aza Compounds; Carbohydrate Metabolism; Deoxyadenosines; Erythrocytes; Fluorine; Humans; Inosine; Mercaptopurine; Nucleosides; Phosphotransferases; Pyrazoles; Pyrimidines; Pyrimidinones; Pyrroles; Ribonucleosides; Structure-Activity Relationship | 1973 |
1,2-fused pyrimidines. VI. Substituted 2-amino-4H-pyrido[1,2-a]pyrimidin-4-ones with antiplatelet activity.
Topics: Adenosine Diphosphate; Calcimycin; Collagen; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrimidinones | 1993 |
Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
Topics: Adenosine Diphosphate; Alkaloids; Blood Platelets; Diacylglycerol Kinase; Diglycerides; Enzyme Activation; Ethers, Cyclic; Humans; Okadaic Acid; Phosphotransferases; Platelet Aggregation; Protein Kinase C; Pyrimidinones; Serotonin; Staurosporine; Thiazoles; Thrombin; Type C Phospholipases | 1993 |
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis.
Topics: Adenosine Diphosphate; Calcimycin; Chromones; Collagen; Coumarins; Humans; Inhibitory Concentration 50; Models, Molecular; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrimidinones; Quantitative Structure-Activity Relationship; Static Electricity; Stereoisomerism | 2003 |
Inhibitory effect of novel pyrimidines on ATP and ADP hydrolysis in synaptosomes from rat cerebral cortex.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brazil; Cerebral Cortex; Enzyme Inhibitors; Hydrolysis; Pyrazoles; Pyrimidines; Pyrimidinones; Rats; Synaptosomes | 2003 |
Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; In Vitro Techniques; Isoenzymes; MAP Kinase Signaling System; Mice; Mice, Knockout; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Aggregation; Protein Kinase Inhibitors; Pyrimidinones; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Signal Transduction; Thromboxane A2 | 2010 |
Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model.
Topics: Adenosine Diphosphate; Animals; Aorta; Aspirin; Blood Platelets; Collagen; Cyclic GMP; Drug Synergism; Inflammation Mediators; Inhibitory Concentration 50; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Pyrimidinones; Rats; Rats, Sprague-Dawley; Thrombin; Thromboplastin; Thrombosis | 2011 |
Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation.
Topics: Adenosine Diphosphate; Analysis of Variance; Cardiac Surgical Procedures; Class I Phosphatidylinositol 3-Kinases; Enzyme-Linked Immunosorbent Assay; Extracorporeal Circulation; Flow Cytometry; Humans; Hypothermia, Induced; In Vitro Techniques; Leukocytes; Models, Biological; Morpholines; P-Selectin; Phosphoinositide-3 Kinase Inhibitors; Platelet Activation; Platelet Count; Purinergic P2 Receptor Antagonists; Pyrimidinones | 2012 |